Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-Current Deferred Tax Liability (2022 - 2023)

Historic Non-Current Deferred Tax Liability for Bicycle Therapeutics (BCYC) over the last 2 years, with Q4 2023 value amounting to $3.4 million.

  • Bicycle Therapeutics' Non-Current Deferred Tax Liability fell 2309.96% to $3.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.4 million, marking a year-over-year decrease of 2309.96%. This contributed to the annual value of $3.4 million for FY2023, which is 2309.96% down from last year.
  • Bicycle Therapeutics' Non-Current Deferred Tax Liability amounted to $3.4 million in Q4 2023, which was down 2309.96% from $4.4 million recorded in Q4 2022.
  • In the past 5 years, Bicycle Therapeutics' Non-Current Deferred Tax Liability ranged from a high of $4.4 million in Q4 2022 and a low of $3.4 million during Q4 2023